Bruce A. Weber
Corporate Officer/Principal at Innovia LLC
Profile
Bruce A.
Weber currently works at Innovia LLC, as VP-Clinical, Regulatory & Quality Assurance.
Mr. Weber also formerly worked at Sernova Corp., as Independent Director from 2012 to 2019, BioNexus Genomics, Inc., as Manufacturing Director, Cordis Corp., as Associate-Senior Regulatory Affairs, Corvita Corp., as Vice President-Product Assurance from 1989 to 1998, Cordis Dow Corp., as Quality Control Manager, Syntheon LLC, as Vice President-Product Assurance from 1998 to 2004, and InnFocus, Inc., as VP-Clinical, Regulatory & Quality Assurance from 2004 to 2017.
Mr. Weber received his undergraduate degree from Bowling Green State University and undergraduate degree and graduate degree from Nova Southeastern University, Inc.
Bruce A. Weber active positions
Companies | Position | Start |
---|---|---|
Innovia LLC
Innovia LLC Medical SpecialtiesHealth Technology Innovia LLC designs and provides medical devices and polymers. It specializes in the development and manufacture of novel biomaterials and innovative medical devices. The company was founded by Leonard Pinchuk and John B. Martin in 2002 and is headquartered in Miami, FL. | Corporate Officer/Principal | - |
Former positions of Bruce A. Weber
Companies | Position | End |
---|---|---|
SERNOVA CORP. | Director/Board Member | 01/05/2019 |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Corporate Officer/Principal | 31/12/2016 |
Syntheon LLC | Corporate Officer/Principal | 31/12/2003 |
Corvita Corp.
Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Corporate Officer/Principal | 31/12/1997 |
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | General Counsel | - |
Training of Bruce A. Weber
Bowling Green State University | Undergraduate Degree |
Nova Southeastern University, Inc. | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SERNOVA CORP. | Health Technology |
Private companies | 7 |
---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Corvita Corp.
Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Health Technology |
BioNexus Genomics, Inc.
BioNexus Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of Ashni Naturaceuticals, Inc., BioNexus Genomics, Inc. develops proprietary drug supplements and functional foods. The company is based in Ithaca, NY. BioNexus Genomics was acquired by Ashni Naturaceuticals, Inc. on January 25, 2000. | Health Technology |
Cordis Dow Corp. | |
Syntheon LLC | |
Innovia LLC
Innovia LLC Medical SpecialtiesHealth Technology Innovia LLC designs and provides medical devices and polymers. It specializes in the development and manufacture of novel biomaterials and innovative medical devices. The company was founded by Leonard Pinchuk and John B. Martin in 2002 and is headquartered in Miami, FL. | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |
- Stock Market
- Insiders
- Bruce A. Weber